DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM). Investors who purchased DexCom securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DXCM. Investigation Details DexCom announced its second quarter earnings on July 25, 2024, including revenue that failed to match an ...